Allgemein- und Viszeralchirurgie up2date, Table of Contents Allgemein- und Viszeralchirurgie up2date 2024; 18(03): 181-203DOI: 10.1055/a-2261-3308 Oberer Gastrointestinaltrakt Adenokarzinome des ösophagogastralen Übergangs Patrick Sven Plum 1 Klinik und Poliklinik für Viszeral-, Transplantations-, Thorax- und Gefäßchirurgie, Universitätsklinik Leipzig, Leipzig, Germany , Ines Gockel 2 Klinik und Poliklinik für Viszeral-, Transplantations-, Thorax- und Gefäßchirurgie, Universitätsklinik Leipzig, Leipzig, Germany › Author AffiliationsRecommend Article Abstract Buy Article All articles of this category Die Adenokarzinome des ösophagogastralen Übergangs (AEG-Tumoren) werden anhand der Tumorlokalisation in Bezug zur Z-Linie als anatomische Landmarke unterteilt. Verschiedene Klassifikationssysteme haben sich hier etabliert (Siewert, Nishi, TNM/UICC). Die genaue Kenntnis über die Tumorlokalisation ist von höchster klinischer Relevanz, da sie wesentlichen Einfluss auf die Operationsstrategie hat. Dieser Beitrag stellt die wesentlichen Aspekte dieser divergenten Tumorgruppe vor. Full Text References Literatur 1 Hayashi T, Yoshikawa T. Optimal surgery for esophagogastric junctional cancer. Langenbecks Arch Surg 2022; 407: 1399-1407 2 Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459 3 Nishi M, Kajisa T, Akune T. et al. Cardia cancer: proposal of cancer in the esophagogastric junction. Geka Shinryo (Surgical Diagnosis Treatment) 1973; 15: 1328-1338 4 Kroese TE, van Rossum PSN, Nilsson M. et al. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: a multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer. Eur J Surg Oncol 2023; 49: 21-28 5 Kroese TE, van Laarhoven HWM, Nilsson M. et al. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: a systematic review and meta-analysis. Eur J Cancer 2022; 166: 254-269 6 Porschen R, Fischbach W, Gockel I. et al. S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Z Gastroenterol 2019; 57: 336-418 7 Porschen R, Fischbach W, Gockel I. et al. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus. United Eur Gastroenterol J 2024; 12: 399-411 8 Lordick F, Carneiro F, Cascinu S. et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 2022; 33: 1005-1020 9 Rice TW, Patil DT, Blackstone EH. AJCC/UICC staging of cancers of the esophagus and esophagogastric junction (8th edn): application to clinical practice. Ann Cardiothorac Surg 2017; 6: 119-130 10 Bayley EM, Ivy ML, Shewale JB. et al. High-risk features of esophageal adenocarcinoma following neoadjuvant chemoradiation: patients for whom surgery should not be delayed. Ann Surg 2023; 277: 721-726 11 Hoeppner J, Plum PS, Buhr H. et al. Chirurgische Therapie des Ösophaguskarzinoms – Qualitätsindikatoren für Diagnostik und Therapie. Chirurg 2021; 92: 350-360 12 Boys JA, Worrell SG, Chandrasoma P. et al. Can the risk of lymph node metastases be gauged in endoscopically resected submucosal esophageal adenocarcinomas? A multi-center study. J Gastrointest Surg 2016; 20: 6-12 13 Al-Haddad MA, Elhanafi SE, Forbes N. et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence. Gastrointest Endosc 2023; 98: 285-305.e38 14 van Hagen P, Hulshof MCCM, van Lanschot JJB. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084 15 Al-batran SE, Hartmann JT, Hofheinz R. et al. Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2008; 19: 1882-1887 16 Langer R, Becker K, Zlobec I. et al. A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy. Ann Surg Oncol 2014; 21: 915-921 17 Realis Luc M, Bonomi AM, Carbone F. et al. Roux-en-Y with or without jejunal J-pouch reconstruction after total gastrectomy for gastric cancer: systematic review and meta-analysis of long-term functional outcomes. J Gastrointest Surg 2024; 28: 291-300 18 Li B, Wang Y, Li B. et al. Short-term outcomes and long-term quality of life of reconstruction methods after proximal gastrectomy: a systematic review and meta-analysis. BMC Cancer 2024; 24: 56 19 Yamashita H, Seto Y, Sano T. et al. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer 2017; 20: 69-83 20 Van der Sluis PC, van der Horst S, May AM. et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann Surg 2019; 269: 621-630 21 Perry R, Barbosa JP, Perry I. et al. Short-term outcomes of robot-assisted versus conventional minimally invasive esophagectomy for esophageal cancer: a systematic review and meta-analysis of 18,187 patients. J Robot Surg 2024; 18: 125 22 Angeramo CA, Bras Harriott C, Casas MA. et al. Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis. Surgery 2021; 170: 1692-1701 23 Jeon YH, Yun JK, Jeong YH. et al. Surgical outcomes of 500 robot-assisted minimally invasive esophagectomies for esophageal carcinoma. J Thorac Dis 2023; 15: 4745-4756 24 Knitter S, Maurer MM, Winter A. et al. Robotic-Assisted Ivor Lewis Esophagectomy Is Safe and Cost Equivalent Compared to Minimally Invasive Esophagectomy in a Tertiary Referral Center. Cancers (Basel) 2023; 16: 112 25 Van der Veen A, Brenkman HJF, Seesing MFJ. et al. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial. J Clin Oncol 2021; 39: 978-989 26 Li ZY, Wei B, Zhou YB. et al. Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study. Br J Surg 2024; 111: znad435 27 Ojima T, Nakamura M, Hayata K. et al. Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg 2021; 156: 954-963 28 van der Werf LR, Busweiler LAD, van Sandick JW. et al. Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg 2019; 271: 1095-1101 29 Low DE, Alderson D, Cecconello I. et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 2015; 262: 286-294 30 Oesophago-Gastric Anastomosis Study Group, West Midlands Research Collaborative. Rates of anastomotic complications and their management following esophagectomy: results of the Oesophago-Gastric Anastomosis Audit (OGAA). Ann Surg on behalf of the 2022; 275: e382-e391 31 Plum PS, Herbold T, Berlth F. et al. Outcome of self-expanding metal stents in the treatment of anastomotic leaks after Ivor Lewis esophagectomy. World J Surg 2019; 43: 862-869 32 Berlth F, Bludau M, Plum PS. et al. Self-expanding metal stents versus endoscopic vacuum therapy in anastomotic leak treatment after oncologic gastroesophageal surgery. J Gastrointest Surg 2019; 23: 67-75 Supplementary Material Supplementary Material Supplementary Material
